The Cognitive Blood Panel: Why Vitamin D, B12 and Omega-3 Belong to Executive Duty
# The Cognitive Blood Panel: Why Vitamin D, B12 and Omega-3 Belong to Executive Duty
There is a sentence in Die Architektur des Denkens that I still find uncomfortable to reread, because it was written against my own prior conviction. The sentence is simple: the molecules in my blood influence directly how well my prefrontal cortex works. For a lawyer and entrepreneur whose entire professional life rests on the assumption that judgement is a matter of training, experience and discipline, this admission is a small intellectual defeat. For a board member who signs off on decisions involving many lives and many millions, it is something more serious. It is a gap in the inventory of one’s own instruments. This essay is an attempt to close that gap, at least by one measured step, through what I have come to call the cognitive blood panel.
Dr. Brandt, or the surgeon who stopped recognising himself
In 2021 I sat across from a cardiac surgeon I describe in the book as Dr. Brandt. He was forty, internationally recognised, the author of more than fifty scientific publications, and he was telling me, carefully, that he no longer recognised his own mind. His operations remained excellent. Motor skill, as the neurosciences have long observed, is robust. What had eroded was something quieter and more consequential: his analytical judgement in clinical meetings, his reading of risk, his ability to hold several considerations in suspension before deciding. He had been through a year of therapy, carrying the working diagnosis of burnout, and the therapy had helped. The feeling of looking at the world through a fogged lens had not lifted.
At my request he ordered an extended blood panel, one that went beyond the standard menu. The numbers, when they arrived, told a coherent and unflattering story. Active B12, measured as holotranscobalamin, stood at 23 pmol/L, well below the functional threshold of 35 pmol/L. The 25-OH-vitamin-D level was 28 nmol/L, a severe deficiency by any reasonable definition. Homocysteine had drifted to 19 micromol/L, almost twice the recommended ceiling. The Omega-3 Index was 3.6 percent, less than half of what the literature regards as optimal. His TSH sat in the upper normal range, in the zone where symptoms already appear for many patients. Four months after the beginning of a targeted supplementation protocol, Dr. Brandt said in a follow-up meeting that it felt as if someone had cleaned the objective of a camera. The sharpness had returned.
From disease-oriented medicine to performance-oriented measurement
One has to understand why a man of Dr. Brandt’s calibre can travel for years through excellent healthcare systems and still end up undiagnosed in the way that matters to him. The reason is structural, not personal. Medicine as it is practised in most industrialised countries is disease-oriented. A blood panel is ordered when someone is ill, in order to cross a threshold between health and pathology. Reference ranges are calibrated against that boundary. They are not calibrated against the boundary between normal and optimal cognitive function, which is the boundary on which executive life is actually lived.
The consequence is a quiet category error. A Vitamin D level of 40 nmol/L is flagged as noteworthy but rarely treated as urgent, because the patient does not present with rickets or fractures. The impairment is subclinical, gradual, and therefore almost invisible to the patient himself, who adapts to his own declining clarity and loses the reference point that would allow him to notice. Kahneman would recognise the pattern. What cannot be compared cannot be corrected. A performance-oriented view of the blood begins precisely where the disease-oriented view ends.
The quartet that deserves a seat at the table
Four parameters, in my reading of the canon, form the minimal cognitive blood panel for anyone whose work consists of judgement under uncertainty. They are holotranscobalamin, 25-OH-vitamin-D, homocysteine and the Omega-3 Index. None of them is exotic. All of them must be actively requested, because none of them sits reliably in the standard menu.
Holotranscobalamin measures the biologically active fraction of Vitamin B12, the part that the nervous system can actually use. Total B12, the default measurement, routinely misses functional deficits because it counts molecules that never reach the neurons. 25-OH-vitamin-D measures the storage form of what is, despite its name, a neurosteroid hormone. Its receptors cluster in the hippocampus and the prefrontal cortex, the two structures on which judgement most directly depends. Homocysteine is a metabolic intermediate whose elevation signals that the methylation pathways supported by B12, folate and B6 are struggling; elevated homocysteine is one of the better documented vascular and cognitive risk markers we possess. The Omega-3 Index, expressed as the percentage of EPA and DHA in red blood cell membranes, captures something structural: the fatty acid composition of the membranes in which every synaptic event takes place.
Read together, these four numbers do not diagnose a disease. They describe the biochemical terrain on which the prefrontal cortex is being asked to operate. In the case of Dr. Brandt, each of the four was pointing in the same direction, and the cumulative effect was a brain asked to perform executive work on a substrate that was materially underresourced.
Biochemistry as fiduciary infrastructure
There is a reason I insist on the word fiduciary in this context. A board member, a private banker, a partner in a law firm owes duties that the law takes seriously. Those duties are habitually translated into governance processes: conflict registers, documentation standards, reporting lines, the architecture of the meeting itself. What is almost never translated into process is the condition of the instrument that performs all of this work, which is the human brain of the decision-maker.
This asymmetry is no longer defensible. If we accept, with the current state of the neurosciences, that the prefrontal cortex is the first system to fail under sleep debt, chronic stress and biochemical deficits, then the biochemical state of the decision-maker is not a private matter of wellness. It is part of the infrastructure on which fiduciary duties are discharged. A board that would not tolerate a missing audit trail should not, in good conscience, tolerate an unmeasured Omega-3 Index in the people it has asked to decide on behalf of others.
I am aware that this sentence will sound excessive to some readers. It would have sounded excessive to me a decade ago. What changed my mind was not rhetoric but cases like Dr. Brandt’s, and the slow accumulation of evidence that the most expensive errors in executive life are very rarely errors of information. They are errors of judgement made by minds operating below their own baseline, under conditions that were, in retrospect, measurable.
A protocol for boards that take their own minds seriously
The protocol I now recommend to boards and to private banking desks that advise principals is deliberately modest. It is not a wellness programme. It is a measurement discipline. Once a year, and ideally at the end of winter in the northern hemisphere, each member obtains the extended panel: holotranscobalamin, 25-OH-vitamin-D, homocysteine, Omega-3 Index, together with a thyroid panel that includes TSH in its full range rather than against a single cutoff. The results are discussed with a physician who understands the distinction between disease thresholds and performance thresholds. Supplementation, where indicated, is targeted and retested, not prescribed indefinitely on faith.
The protocol stops there. It does not promise enhancement, because enhancement is not the point. The point is the removal of silent handicaps. A Vitamin D level restored from 28 to 80 nmol/L does not turn an average director into a brilliant one. It allows a capable director to operate at the level at which he was already being paid to operate. That is a different, more honest promise, and it is the one that the canon of Die Architektur des Denkens consistently makes.
There is also a cultural consequence that I consider at least as important as the biochemical one. When a board treats the cognitive blood panel as part of its ordinary hygiene, it signals something about its relationship to its own fallibility. It accepts, in practice and not only in theory, that the instrument of judgement is material, perishable and worth maintaining. That acceptance, in my experience, changes other conversations in the room. It makes it easier to admit uncertainty, easier to ask for a pre-mortem, easier to concede that a strong feeling of conviction is not the same as being right.
I have written elsewhere, and I repeat here, that Dr. Raphael Nagel (LL.M.) did not arrive at these conclusions through enthusiasm for supplements. I arrived at them through years of watching intelligent people, myself included, make decisions whose poor quality could not be explained by any deficit of information, experience or character. Somewhere behind the visible layer of reasoning there was another layer, quieter and more material, which the standard vocabulary of corporate governance had no words for. The cognitive blood panel is one of the few instruments I know that gives that layer a vocabulary and a number. It does not replace the stoic discipline of self-observation, the Talmudic habit of argument, or the Kahnemanian suspicion of one’s own certainties. It sits underneath them, as a floor sits underneath a room. A floor that has quietly given way will eventually take the room with it, regardless of how the furniture has been arranged. For those of us who continue to accept fiduciary responsibility for other people’s capital, other people’s health and other people’s futures, the argument of Dr. Raphael Nagel (LL.M.) in this essay is therefore not an appeal to self-optimisation. It is an argument about the conditions under which executive duty can be honestly discharged. The blood, read carefully and in the right parameters, is one of those conditions. It deserves a place in the minutes.
Claritáte in iudicio · Firmitáte in executione
For weekly analysis on capital, leadership and geopolitics: follow Dr. Raphael Nagel (LL.M.) on LinkedIn →